These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 19844969)

  • 1. Use of liquid chromatography/tandem mass spectrometric molecular fingerprinting for the rapid structural identification of pharmaceutical impurities.
    Li M; Wang X; Chen B; Lin M; Buevich AV; Chan TM; Rustum AM
    Rapid Commun Mass Spectrom; 2009 Nov; 23(22):3533-42. PubMed ID: 19844969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of LC-MS(n) in conjunction with mechanism-based stress studies in the elucidation of drug impurity structure: rapid identification of a process impurity in betamethasone 17-valerate drug substance.
    Li M; Lin M; Rustum A
    J Pharm Biomed Anal; 2008 Dec; 48(5):1451-6. PubMed ID: 18977106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid structure elucidation of drug degradation products using mechanism-based stress studies in conjunction with LC-MS(n) and NMR spectroscopy: identification of a photodegradation product of betamethasone dipropionate.
    Lin M; Li M; Buevich AV; Osterman R; Rustum AM
    J Pharm Biomed Anal; 2009 Oct; 50(3):275-80. PubMed ID: 19525081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On-line H/D exchange LC-MS strategy for structural elucidation of pharmaceutical impurities.
    Liu DQ; Wu L; Sun M; MacGregor PA
    J Pharm Biomed Anal; 2007 Jun; 44(2):320-9. PubMed ID: 17317074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel rapamycin derivatives as low-level impurities in active pharmaceutical ingredients.
    Zech SG; Carr M; Mohemmad QK; Narasimhan NI; Murray C; Rozamus LW; Dalgarno DC
    J Antibiot (Tokyo); 2011 Sep; 64(9):649-54. PubMed ID: 21792211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
    Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
    J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and structural elucidation of two process impurities and stress degradants in darifenacin hydrobromide active pharmaceutical ingredient by LC-ESI/MS(n).
    Thomas S; Paul SK; Shandilya S; Agarwal A; Saxena N; Awasthi AK; Matta Hb; Vir D; Mathela CS
    Analyst; 2012 Aug; 137(15):3571-82. PubMed ID: 22733388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an information-rich LC-MS/MS database for the analysis of drugs in postmortem specimens.
    Liu HC; Liu RH; Ho HO; Lin DL
    Anal Chem; 2009 Nov; 81(21):9002-11. PubMed ID: 19788251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly efficient, selective, sensitive and stability indicating RP-HPLC-UV method for the quantitative determination of potential impurities and characterization of four novel impurities in eslicarbazepine acetate active pharmaceutical ingredient by LC/ESI-IT/MS/MS.
    Thomas S; Bharti A; Maddhesia PK; Shandilya S; Agarwal A; Dharamvir ; Biswas S; Bhansal V; Gupta AK; Tewari PK; Mathela CS
    J Pharm Biomed Anal; 2012 Mar; 61():165-75. PubMed ID: 22178334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure elucidation of highly polar basic degradants by on-line hydrogen/deuterium exchange hydrophilic interaction chromatography coupled to tandem mass spectrometry.
    Liu M; Ronk M; Ren D; Ostovic J; Cauchon N; Zhou ZS; Cheetham J
    J Chromatogr A; 2010 May; 1217(22):3598-611. PubMed ID: 20417519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analysis of photo-degradation in thiazole-containing compounds by LC-MS/MS and NMR.
    Wu L; Hong TY; Vogt FG
    J Pharm Biomed Anal; 2007 Jul; 44(3):763-72. PubMed ID: 17442527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of uremic analytes in hemodialysate and their structural elucidation from accurate mass maps generated by a multi-dimensional liquid chromatography/mass spectrometry approach.
    Godfrey AR; Williams CM; Dudley E; Newton RP; Willshaw P; Mikhail A; Bastin L; Brenton AG
    Rapid Commun Mass Spectrom; 2009 Oct; 23(19):3194-204. PubMed ID: 19718779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the 'wrong' active pharmaceutical ingredient in a counterfeit Halfan drug product using accurate mass electrospray ionisation mass spectrometry, accurate mass tandem mass spectrometry and liquid chromatography/mass spectrometry.
    Wolff JC; Thomson LA; Eckers C
    Rapid Commun Mass Spectrom; 2003; 17(3):215-21. PubMed ID: 12539187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent studies on the electrospray ionisation mass spectrometric behaviour of selected nitrogen-containing drug molecules and its application to drug analysis using liquid chromatography-electrospray ionisation mass spectrometry.
    Smyth WF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 824(1-2):1-20. PubMed ID: 16095984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the detection of degradants and impurities in pharmaceutical drug products by applying mass spectral and chromatographic searching.
    Freed AL; Kale U; Ando H; Rossi DT; Kingsmill CA
    J Pharm Biomed Anal; 2004 Jun; 35(4):727-38. PubMed ID: 15193717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragmentation study on the phenolic alkaloid neferine and its analogues with anti-HIV activities by electrospray ionization tandem mass spectrometry with hydrogen/deuterium exchange and its application for rapid identification of in vitro microsomal metabolites of neferine.
    Zhou H; Jiang H; Yao T; Zeng S
    Rapid Commun Mass Spectrom; 2007; 21(13):2120-8. PubMed ID: 17546644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of hyphenated LC-MS techniques in pharmaceutical analysis.
    Ermer J; Vogel M
    Biomed Chromatogr; 2000 Oct; 14(6):373-83. PubMed ID: 11002275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification, characterization and quantification of new impurities by LC-ESI/MS/MS and LC-UV methods in rivastigmine tartrate active pharmaceutical ingredient.
    Thomas S; Shandilya S; Bharati A; Paul SK; Agarwal A; Mathela CS
    J Pharm Biomed Anal; 2012 Jan; 57():39-51. PubMed ID: 21880452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of amodiaquine bulk drug impurities by liquid chromatography/ion trap mass spectrometry.
    Dongre VG; Karmuse PP; Ghugare PD; Kanojiya SK; Rawal S
    Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2227-33. PubMed ID: 18543378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein identification assisted by the prediction of retention time in liquid chromatography/tandem mass spectrometry.
    Wang Y; Zhang J; Gu X; Zhang XM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Nov; 826(1-2):122-8. PubMed ID: 16159714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.